Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease. - Wikidata - awgldk - TriplyDB

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

http://www.wikidata.org/entity/Q37609642

about

Inhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats

P2860

Q59138055-F56DF479-72AD-4F88-BC56-920F51BB2487

P2860

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

http://www.wikidata.org/entity/Q37609642

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@en

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@nl

type

label

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@en

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@nl

prefLabel

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@en

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@nl

P1433

Q37609642-A9C73B36-8944-4A75-A693-0E453E8D44E4

P1476

Q37609642-B342D4A1-7603-4AC7-B4C8-9EA678EB983A

P2093

Q37609642-5EB87BF8-4857-42DC-AF35-84DC468D9121

Q37609642-81A8AC7F-D255-45EC-BCA2-14C01F918129

P2860

Q37609642-0F2C637A-D1C1-445B-85DB-B1FD4068A66D

Q37609642-1EB400B2-2999-47B7-AFF5-50812C3FD585

Q37609642-200A0A5A-7C47-491A-BCC1-F812F4861265

Q37609642-3631D6E2-40FE-4839-BBAC-5EA1F087F3D9

Q37609642-38013E3B-9453-4F91-AF9F-80CBE1CC9EAE

Q37609642-7BD01171-ECDF-4235-AB87-E6347D2974CB

Q37609642-A14C2CE3-1A4C-4184-81C7-859F2390E6BF

Q37609642-A43C28EF-1518-4F17-8FA0-404B00EE1BB5

Q37609642-A5A67210-7F34-4D38-B3E0-550A789B17B6

Q37609642-CC578C79-CBCC-4AC1-B808-959CCC7C3933

P304

Q37609642-3B344A4B-2025-4D19-AA57-39DB1F9F6641

P31

Q37609642-52A6DC83-6D37-4C3A-99DD-47776B544B66

P356

Q37609642-6CAEF670-BE14-4DAE-8493-E7A69CC126E1

P407

Q37609642-15443E4C-B81F-4B84-8826-2D31582D9C5E

P433

Q37609642-B73CEC54-D251-45CC-A781-34046B215321

P478

Q37609642-8AA83C7A-5285-484F-A14C-9E3445921B8D

P577

Q37609642-C080ADFC-382F-42B7-BBBF-1F870A11F375

P698

Q37609642-2D3B304D-2FD9-4006-80FF-87A2BB60DFC1

P921

Q37609642-0A5F4F92-C88E-45DD-93F3-9F570ADDB105

P932

Q37609642-409A7AEE-7500-4C1C-BF2E-229FD360E97F

P356

P1433

Journal of Clinical Investigation

P1476

Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

@en

P2093

Allison S Limpert

http://www.w3.org/2001/XMLSchema#string

Nicholas D P Cosford

http://www.w3.org/2001/XMLSchema#string

P2860

Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)

Glutamate and epilepsy

Glutamate metabotropic receptors as targets for drug therapy in epilepsy

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1

Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection

Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.

Structure-activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators.

The preclinical discovery of amyotrophic lateral sclerosis drugs.

P304

964-967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI74608

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24569369

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

3938264

http://www.w3.org/2001/XMLSchema#string